W. D. de Leng

Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)

I. B. Borel Rinkes, M. Koopman, O. Kranenburg, 2017, BMC Cancer.

Intestinal renin–angiotensin system is stimulated after deletion of Lkb1

A. Ashworth, T. Dale, A. Clarke, 2011, Gut.

Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma

P. Lambin, H. Woodruff, O. Schijns, 2021, Cancers.

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

E. Cuppen, E. Smit, P. Roepman, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy

P. Roepman, L. Hoes, P. Snaebjornsson, 2024, The Journal of pathology.

Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types

P. Roepman, E. Voest, H. Gelderblom, 2021, Clinical Cancer Research.

Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP).

P. Roepman, L. Zeverijn, V. Noort, 2024, European journal of cancer.

Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort

M. J. van den Bent, B. Ylstra, B. Westerman, 2023, Neuro-oncology advances.

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations

H. Groen, E. Schuuring, W. Dinjens, 2020, The oncologist.